Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05057663Unknown
Randomised, open-label trial in plantar wart comparing Bleomycin group with 5-Fluorouracil group (2 arms). Primary endpoint: Response to intralesional injection of bleomycin, 5fluorouracil in treatment of plantar wart at 3 months. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05057663.